Christopher Francis, Ph.D.

Christopher Francis, Ph.D.

Senior Vice President, Corporate Development and Head of Emerging AreasatWave Life Sciences· In proxies 2022–2024

Pay in FY2023+51% from the year before · Wave Life Sciences stock -27.9% the same year

Christopher Francis, Ph.D. was paid $1.5M in FY2023 (Dec), up 51%. Wave Life Sciences stock fell 27.9% that year.

Pay$100 in the stock at the end of FY21 → $161
Pay is from the Summary Compensation Table of each Wave Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Wave Life SciencesPublic company · 4 yr
    • Senior Vice President, Corporate Development and Head of Emerging Areas2022 – Present · 4 yrStock in role +4%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?